AbCellera Biologics Inc. (ABCL)
NASDAQ: ABCL · Real-Time Price · USD
2.850
+0.140 (5.17%)
At close: Dec 20, 2024, 4:00 PM
2.800
-0.050 (-1.75%)
After-hours: Dec 20, 2024, 6:39 PM EST
AbCellera Biologics Market Cap
AbCellera Biologics has a market cap or net worth of $841.79 million as of December 20, 2024. Its market cap has decreased by -40.06% in one year.
Market Cap
841.79M
Enterprise Value
270.05M
1-Year Change
-40.06%
Ranking
Category
Stock Price
$2.85
Market Cap Chart
Since the IPO on December 11, 2020, AbCellera Biologics's market cap has decreased from $15.66B to $841.79M, a decrease of -94.63%. That is a compound annual growth rate of -51.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 841.79M | -49.19% |
| Dec 29, 2023 | 1.66B | -42.83% |
| Dec 30, 2022 | 2.90B | -28.02% |
| Dec 31, 2021 | 4.03B | -62.83% |
| Dec 31, 2020 | 10.83B | -30.85% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Phibro Animal Health | 878.52M |
| Pacira BioSciences | 876.37M |
| AMN Healthcare Services | 872.27M |
| Cogent Biosciences | 866.02M |
| Paragon 28 | 839.72M |
| Healthcare Services Group | 828.19M |
| uniQure | 827.66M |
| Prothena Corporation | 818.97M |